AI/ML Innovations Inc. Announces Shares for Debt Transaction
AI/ML Innovations Inc. Announces Shares for Debt Transaction
VICTORIA, BC / ACCESSWIRE / June 14, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into a shares for debt transaction with Wonderful Ventures LLC of Las Vegas, Nevada ("WV"). The Company entered into a finder's agreement dated June 7, 2024 with WV wherein WV would assist the Company in the search for a new CEO. Pursuant to the terms of the Finder's Agreement, the Company will pay CAD $67,600 to WV by a cash payment of $30,000 and the issuance of C$37,600 in Common Shares of the Company (the "Shares for Debt Transaction"). Pursuant to the Shares for Debt Transaction, the Company will issue an aggregate of 750,000 Common Shares, at a deemed price of $0.05 per Common Share. The proposed Shares for Debt Transaction is subject to the approval of the Canadian Securities Exchange.
2024年6月14日/ ACCESSWIRE /加拿大人工智能/機器學習創新公司（以下簡稱“公司”）（CSE：AIML）（OTCQB：AIMLF）（FWB：42FB）宣佈已與內華達州拉斯維加斯的Wonderful Ventures LLC（以下簡稱“WV”）進行股份交易以彌補債務。公司與WV簽訂了一份於2024年6月7日的尋找新CEO的中介協議，根據發現者協議的條款，公司將通過現金支付CAD $67,600（其中$30,000爲現金，C $37,600爲公司普通股（“股份交易”））向WV支付。根據股份交易條款，公司將以每股$0.05的價格發行總計750,000股普通股。擬議的股份交易需經加拿大證券交易所批准。
The Common Shares issued will be subject to a four-month hold period.
發行的普通股將受到四個月的持有期限。
About AI/ML Innovations Inc.
關於人工智能/機器學習創新公司。
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
更多關於AI/ML創新公司的信息
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
謹代表董事會
AI/ML Innovations Inc.已重新調整其業務運營以利用人工智能（AI）和機器學習（ML）的蓬勃發展，初始投資重點放在利用AI、ML、雲計算和數字平台推動變革性健康管理解決方案和精準支持交付的新興數字健康和健康公司上。通過與健康儀表盤（AIML持有95.2%的所有權）、Tech2Heal（最高持股22%，目前AIML擁有12.44%的所有權）、AI Rx Inc.（AIML持有70%的所有權）和其他計劃中的增值投資進行戰略合作，該公司繼續利用不斷擴大的增長領域，造福於公司的所有利益相關者。AI/ML的股票在加拿大證券交易所上市，代碼爲“AIML”，在OTCQB Venture Market上市，代碼爲“AIMLF”，在Frankfurt Stock Exchange上市，代碼爲“42FB”。
For more information about AI/ML Innovations:
執行董事Tim Daniels:
For detailed information please see AI/ML's website or the Company's filed documents at .
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
有關詳細信息，請參見AI/ML的網站或公司在...的文件。
如需更多信息，請聯繫Blake Fallis，電話：（778）405-0882或電子郵件：info@aiml-innovations.com。
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
本新聞稿不構成在任何司法管轄區出售或購買任何證券的要約，也不應該有任何在美國任何州出售或購買證券的要約、出售或徵求。
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
加拿大證券交易所及其監管服務提供商（如該術語所定義的CSE政策）概不負責本發佈的充分性或準確性。
加拿大證券交易所及其監管服務提供商（如該術語所定義的CSE政策）概不負責本發佈的充分性或準確性。
SOURCE: AI/ML Innovations Inc.
來源：AI/ML Innovations Inc.
譯文內容由第三人軟體翻譯。